Picture of Kyowa Kirin Co logo

4151 Kyowa Kirin Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+12.26%
3m+3.51%
6m-6.95%
1yr-29.37%
Volume Change (%)
10d/3m+92.12%
Price vs... (%)
52w High-8.35%
50d MA+18.45%
200d MA+11.58%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)22.46
PEG Ratio (f)n/a
EPS Growth (f)-13.09%
Dividend Yield (f)2%
Valuation (ttm)IndustryMarket
Price to Book Value1.86
Price to Tang. Book2.45
Price to Free Cashflow18.77
Price to Sales3.51
EV to EBITDA10.39

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital10.37%
Return on Equity10.15%
Operating Margin20.93%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue¥m305,820318,352352,246398,371442,233450,627468,16210.25%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+27.01+12+4.4+22.26+16.44-15.79+8.12n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Kyowa Kirin Co EPS forecast chart

Profile Summary

Kyowa Kirin Co Ltd, formerly Kyowa Hakko Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of prescription pharmaceuticals. The Company operates in a single pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has POTELLIGENT technology for producing active antibodies. The Company provides products include Poteligeo for the treatment of mycosis fungoides and sezary syndrome, and Crysvita for the treatment of X chromosome-linked hypophosphatemia. Besides, the Company also develops, manufactures, and markets biosimilar drugs, and engages in contracting, wholesale and retail business, and insurance agency business. The Company operates in Japan and overseas.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 1st, 1949
Public Since
August 22nd, 1949
No. of Employees
5,982
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
537,609,288

4151 Share Price Performance

Upcoming Events for 4151

Kyowa Kirin Co Ltd Annual Shareholders Meeting

Q1 2024 Kyowa Kirin Co Ltd Earnings Release

Dividend For 4151.T - 29.0000 JPY

Q2 2024 Kyowa Kirin Co Ltd Earnings Release

Similar to 4151

Picture of Astellas Pharma logo

Astellas Pharma

jp flag iconTokyo Stock Exchange

Picture of Astena Holdings Co logo

Astena Holdings Co

jp flag iconTokyo Stock Exchange

Picture of CanBas Co logo

CanBas Co

jp flag iconTokyo Stock Exchange

Picture of CellSeed logo

CellSeed

jp flag iconTokyo Stock Exchange

FAQ